BSE Live
Nov 14, 16:01Prev. Close
417.05
Open Price
415.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:57Prev. Close
417.00
Open Price
414.75
Bid Price (Qty.)
411.15 (7561)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Biocon (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 870.90 | 1,002.60 | 453.10 | 688.10 | 751.30 | |
| Net CashFlow From Operating Activities | 1,283.10 | 1,154.60 | 662.10 | 640.00 | 370.60 | |
| Net Cash Used In Investing Activities | -1,558.90 | -713.80 | -684.00 | -498.50 | -1,141.70 | |
| Net Cash Used From Financing Activities | 387.60 | -241.70 | -239.70 | -177.50 | 1,067.60 | |
| Foreign Exchange Gains / Losses | 53.60 | 11.20 | 0.40 | -11.30 | 3.50 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 165.40 | 210.30 | -261.20 | -47.30 | 300.00 | |
| Cash And Cash Equivalents Begin of Year | 659.30 | 449.00 | 710.20 | 757.50 | 457.50 | |
| Cash And Cash Equivalents End Of Year | 824.70 | 659.30 | 449.00 | 710.20 | 757.50 |
14.11.2025
12.11.2025
Biocon Standalone September 2025 Net Sales at Rs 583.30 crore, up 11.02% Y-o-Y
10.11.2025
07.11.2025